Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-15

FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for Buspirone hydrochloride from Oxford Pharmaceuticals, LLC, finalizing regulatory approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone hydrochloride (buspirone hydrochloride)

Snippet

SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)